Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02190's Days Payable is ranked better than 57.93% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 68.615
vs HKSE:02190: 82.95
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zylox-Tonbridge Medical Technology Co Days Payable Chart
HKSE:02190 vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Zylox-Tonbridge Medical Technology Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zylox-Tonbridge Medical Technology Co Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zylox-Tonbridge Medical Technology Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Zylox-Tonbridge Medical Technology Co's Days Payable falls into.
Zylox-Tonbridge Medical Technology Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zylox-Tonbridge Medical Technology Co (HKSE:02190) has a Days Payable of 77.81 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zylox-Tonbridge Medical Technology Co and its competitors. This is 17% below median its historical median of 93.95. Over the past decade, Zylox-Tonbridge Medical Technology Co's Days Payable has ranged from 78.08 to 207.46. According to the industry distribution chart, Zylox-Tonbridge Medical Technology Co ranks #334 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 42.1%.
Is Zylox-Tonbridge Medical Technology Co's Days Payable too high?
Zylox-Tonbridge Medical Technology Co's current Days Payable of 77.81 is 17% below median its 10-year median of 93.95. Over the past 10 years, this metric has ranged from a low of 78.08 to a high of 207.46. The Medical Devices & Instruments industry median Days Payable is 68.62. Zylox-Tonbridge Medical Technology Co's value of 77.81 is 13.4% above this industry median. Based on the distribution chart, Zylox-Tonbridge Medical Technology Co ranks #334 out of 794 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Zylox-Tonbridge Medical Technology Co has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zylox-Tonbridge Medical Technology Co's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Zylox-Tonbridge Medical Technology Co ranks #334 out of 794 companies for Days Payable. This puts Zylox-Tonbridge Medical Technology Co in the upper half of its industry. The industry median Days Payable is 68.62. Zylox-Tonbridge Medical Technology Co's value of 77.81 is 13.4% above this benchmark. Historically, Zylox-Tonbridge Medical Technology Co's own Days Payable has ranged from 78.08 to 207.46 over the past decade. While the company's 10-year median is 93.95 vs. the industry median of 68.62, Zylox-Tonbridge Medical Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.62, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zylox-Tonbridge Medical Technology Co's current Days Payable of 77.81 is 13.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Zylox-Tonbridge Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zylox-Tonbridge Medical Technology Co's current Days Payable is 77.81, which is 17% below median its own 10-year median of 93.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zylox-Tonbridge Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Zylox-Tonbridge Medical Technology Co (HKSE:02190) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$35.80, compared to a current price of HK$19.95 — trading 44.3% below its estimated fair value. The current Days Payable is 77.81, which is 17% below median its 10-year median of 93.95 and 13.4% above the Medical Devices & Instruments industry median of 68.62. Zylox-Tonbridge Medical Technology Co's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Zylox-Tonbridge Medical Technology Co (HKSE:02190), the current Days Payable is 77.81 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zylox-Tonbridge Medical Technology Co (HKSE:02190) Overvalued in 2026?
Based on GuruFocus' analysis, Zylox-Tonbridge Medical Technology Co stock appears to be undervalued.
The current stock price of HK$19.95 is trading 44.3% below its estimated GF Value™ of HK$35.80.
GuruFocus considers Zylox-Tonbridge Medical Technology Co to be Significantly Undervalued.
Key valuation signals for HKSE:02190:
Days Payable: 77.81 (17% below median its 10-year median of 93.95)
GF Value™: HK$35.80 vs. price of HK$19.95 (44.3% below fair value)
Industry Position: 13.4% above the Medical Devices & Instruments median (#334 of 794)
No single metric tells the full story. See the HKSE:02190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's products include Thrombite Clot Retriever Device (Thrombite CRD), Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB), and others. The company derives majority of its revenue from PRC.
82GF Score
Get the complete analysis for HKSE:02190
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02190 has been successfully added to your 
